Dun Wang1, Qiang Fu2, Jingling Tang3, Michael Hackett4, Yongjun Wang2, Feng Liu4. 1. Key Laboratory of Structure-Based Drug Design & Discovery, Ministry of Education, Shenyang Pharmaceutical University, Shenyang, 110016,China. 2. Department of Pharmaceutics, School of Pharmacy, Shenyang Pharmaceutical University, Shenyang, 110016, China. 3. School of Pharmacy, Harbin Medical University, Harbin, 150081, China. 4. Division of Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
Abstract
AIM: In this study, we aim to construct nanoformulation with high-cargo loading and controlled serum kinetics. MATERIALS & METHODS: Molecular-matched materials (MMMs) are established through the conjugation of the functional moiety to a molecule representative of the nanoparticle's core. Molecular-matched nanoemulsions and liposomes were prepared using MMMs. RESULTS: This technique based on MMMs even allows us to efficiently load either hydrophobic or hydrophilic moieties into a hydrophobic core of the nanoparticles. MMMs-based nanoparticles showed marked improvement in serum pharmacokinetics and anticancer effect. CONCLUSION: The desired performance can be achieved when the hydrophobic anchor of the PEG derivatives and the moiety conjugated to the therapeutic (or imaging) agents are molecularly identical to the core.
AIM: In this study, we aim to construct nanoformulation with high-cargo loading and controlled serum kinetics. MATERIALS & METHODS: Molecular-matched materials (MMMs) are established through the conjugation of the functional moiety to a molecule representative of the nanoparticle's core. Molecular-matched nanoemulsions and liposomes were prepared using MMMs. RESULTS: This technique based on MMMs even allows us to efficiently load either hydrophobic or hydrophilic moieties into a hydrophobic core of the nanoparticles. MMMs-based nanoparticles showed marked improvement in serum pharmacokinetics and anticancer effect. CONCLUSION: The desired performance can be achieved when the hydrophobic anchor of the PEG derivatives and the moiety conjugated to the therapeutic (or imaging) agents are molecularly identical to the core.
Entities:
Keywords:
PEGylation; imaging; long circulation; molecular-matched nanoparticles; paclitaxel
Authors: Siqing Fu; Aung Naing; Stacy L Moulder; Kirk S Culotta; David C Madoff; Chaan S Ng; Timothy L Madden; Gerald S Falchook; David S Hong; Razelle Kurzrock Journal: Mol Cancer Ther Date: 2011-05-13 Impact factor: 6.261
Authors: Yan Ma; Dan Liu; Dun Wang; Yongjun Wang; Qiang Fu; John K Fallon; Xinggang Yang; Zhonggui He; Feng Liu Journal: Mol Pharm Date: 2014-04-21 Impact factor: 4.939